| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | D Feldman | |
| A Krishnan | |||
| R Bouillon | |||
| A Verstuyf | |||
| E Vanoirbeek | |||
| G Eelen | |||
| L Verlinden | |||
| P2860 | cites work | 1 alpha,25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo | Q74113984 |
| The Vitamin D analogue TX 527 blocks NF-kappaB activation in peripheral blood mononuclear cells of patients with Crohn's disease | Q79267816 | ||
| Vitamin D and cancer | Q79369886 | ||
| Immunohistochemical expression of Ki-67 antigen, cox-2 and Bax/Bcl-2 in prostate cancer; prognostic value in biopsies and radical prostatectomy specimens | Q81156632 | ||
| Vitamin D stimulates apoptosis in gastric cancer cells in synergy with trichostatin A /sodium butyrate-induced and 5-aza-2'-deoxycytidine-induced PTEN upregulation | Q24296637 | ||
| Modulation of the vitamin D3 response by cancer-associated mutant p53 | Q24302430 | ||
| 15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers | Q24318523 | ||
| Unraveling insulin-like growth factor binding protein-3 actions in human disease | Q24650060 | ||
| Regulation of multiple insulin-like growth factor binding protein genes by 1alpha,25-dihydroxyvitamin D3. | Q24816287 | ||
| Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor. | Q25256835 | ||
| Cancer-related inflammation | Q27860907 | ||
| Vitamin D. | Q27919675 | ||
| Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues | Q28192400 | ||
| Cyclooxygenase-2 and prostate carcinogenesis | Q28195207 | ||
| Aspirin and colon cancer--targeting prevention? | Q28211364 | ||
| Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer | Q28218639 | ||
| Constitutive activation of IkappaB kinase alpha and NF-kappaB in prostate cancer cells is inhibited by ibuprofen | Q28377754 | ||
| Calcitriol-induced apoptosis in LNCaP cells is blocked by overexpression of Bcl-2 | Q28378170 | ||
| The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1 alpha,25(OH)2-vitamin D3 in vivo and in vitro | Q28580194 | ||
| NF-kappaB at the crossroads of life and death | Q29619302 | ||
| Molecular mechanisms of breast cancer metastases to bone | Q30436458 | ||
| Treatment of K562 cells with 1,25-dihydroxyvitamin D3 induces distinct alterations in the expression of apoptosis-related genes BCL2, BAX, BCLXL, and p21. | Q39846248 | ||
| Calbindin-D28K prevents drug-induced dopaminergic neuronal death by inhibiting caspase and calpain activity | Q39991930 | ||
| 1alpha,25-dihydroxyvitamin D3 (Calcitriol) inhibits hypoxia-inducible factor-1/vascular endothelial growth factor pathway in human cancer cells | Q40146275 | ||
| Inhibition of bone resorption, rather than direct cytotoxicity, mediates the anti-tumour actions of ibandronate and osteoprotegerin in a murine model of breast cancer bone metastasis. | Q40210622 | ||
| 15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer | Q40248466 | ||
| Identification and characterization of a response element in the EGFR promoter that mediates transcriptional repression by 1,25-dihydroxyvitamin D3 in breast cancer cells | Q40387192 | ||
| Vitamin D sensitizes breast cancer cells to the action of H2O2: mitochondria as a convergence point in the death pathway | Q40407718 | ||
| Vitamin D analog EB1089 triggers dramatic lysosomal changes and Beclin 1-mediated autophagic cell death. | Q40419639 | ||
| Cyclooxygenase inhibitors suppress aromatase expression and activity in breast cancer cells. | Q40462696 | ||
| Vitamin D enhances caspase-dependent and independent TNF-induced breast cancer cell death: the role of reactive oxygen species | Q40576095 | ||
| Vitamin D inhibits G1 to S progression in LNCaP prostate cancer cells through p27Kip1 stabilization and Cdk2 mislocalization to the cytoplasm | Q40637846 | ||
| 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells | Q40859289 | ||
| Regulation of estrogen receptor-alpha gene expression by 1, 25-dihydroxyvitamin D in MCF-7 cells | Q40916283 | ||
| Effects of a new synthetic vitamin D analogue, EB1089, on the oestrogen-responsive growth of human breast cancer cells | Q41464042 | ||
| Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. | Q41628042 | ||
| Increased NF-kappaB activity in fibroblasts lacking the vitamin D receptor | Q42491472 | ||
| Involvement of different nuclear hormone receptors in butyrate-mediated inhibition of inducible NF kappa B signalling | Q42513043 | ||
| Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma. | Q42514552 | ||
| Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. | Q42859934 | ||
| Photoprotection by 1alpha,25-dihydroxyvitamin D and analogs: further studies on mechanisms and implications for UV-damage | Q43095700 | ||
| Suppression of RelB-mediated manganese superoxide dismutase expression reveals a primary mechanism for radiosensitization effect of 1alpha,25-dihydroxyvitamin D(3) in prostate cancer cells | Q43116169 | ||
| Vitamin D may reduce prostate cancer metastasis by several mechanisms including blocking Stat3. | Q43245600 | ||
| A phase II trial of calcitriol and naproxen in recurrent prostate cancer. | Q43295148 | ||
| Demonstration of proteinase inhibitors cystatin A, B and C in breast cancer and in cell lines MCF-7 and ZR-75-1. | Q43587581 | ||
| Aromatase and COX-2 expression in human breast cancers | Q43890516 | ||
| COX-2 in cancer--a player that's defining the rules | Q43963620 | ||
| The p38 and JNK pathways cooperate to trans-activate vitamin D receptor via c-Jun/AP-1 and sensitize human breast cancer cells to vitamin D(3)-induced growth inhibition | Q43976249 | ||
| 1,25-Dihydroxyvitamin D down-regulates cell membrane growth- and nuclear growth-promoting signals by the epidermal growth factor receptor | Q44104172 | ||
| Vitamin D receptor is not required for the rapid actions of 1,25-dihydroxyvitamin D3 to increase intracellular calcium and activate protein kinase C in mouse osteoblasts | Q44309207 | ||
| Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1 | Q44427386 | ||
| Anti-endothelial properties of 1,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of calcitriol | Q44958288 | ||
| Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells | Q46051825 | ||
| Inhibition of p38 by vitamin D reduces interleukin-6 production in normal prostate cells via mitogen-activated protein kinase phosphatase 5: implications for prostate cancer prevention by vitamin D. | Q46058683 | ||
| Membrane initiated signaling by 1,25alpha-dihydroxyvitamin D3 in LNCaP prostate cancer cells | Q46581468 | ||
| Vitamin D receptor (VDR) ablation alters carcinogen-induced tumorigenesis in mammary gland, epidermis and lymphoid tissues | Q46660080 | ||
| Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates. | Q51803777 | ||
| Comparative effects of 1,25(OH)2D3 and EB1089 on cell cycle kinetics and apoptosis in MCF-7 breast cancer cells. | Q52525004 | ||
| Vitamin D inhibits the formation of prostatic intraepithelial neoplasia in Nkx3.1;Pten mutant mice. | Q53341307 | ||
| Regulation of transforming growth factor-beta type II receptor expression in human breast cancer MCF-7 cells by vitamin D3 and its analogues. | Q54141728 | ||
| Autophagy as a basis for the health-promoting effects of vitamin D | Q59487775 | ||
| Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene | Q71826297 | ||
| Vitamin D receptors in breast cancer cells | Q72607738 | ||
| 1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture | Q72878839 | ||
| 1,25-Dihydroxyvitamin D3 decreases human prostate cancer cell adhesion and migration | Q73064955 | ||
| Vitamin D analogues suppress IGF-I signalling and promote apoptosis in breast cancer cells | Q73446751 | ||
| Tissue-selective regulation of aromatase expression by calcitriol: implications for breast cancer therapy | Q33577548 | ||
| MicroRNAs181 regulate the expression of p27Kip1 in human myeloid leukemia cells induced to differentiate by 1,25-dihydroxyvitamin D3 | Q33583422 | ||
| Down-regulation of NF-kappa B protein levels in activated human lymphocytes by 1,25-dihydroxyvitamin D3. | Q33748424 | ||
| Genomic vitamin D signaling in breast cancer: Insights from animal models and human cells. | Q34005554 | ||
| Aromatase--a brief overview | Q34112633 | ||
| Epigenetic control of a VDR-governed feed-forward loop that regulates p21(waf1/cip1) expression and function in non-malignant prostate cells | Q34723871 | ||
| Suppression of prostate cancer cell rolling and adhesion to endothelium by 1α,25-dihydroxyvitamin D3. | Q34756280 | ||
| The iroquois homeobox gene 5 is regulated by 1,25-dihydroxyvitamin D3 in human prostate cancer and regulates apoptosis and the cell cycle in LNCaP prostate cancer cells | Q34783905 | ||
| The seed and soil hypothesis revisited--the role of tumor-stroma interactions in metastasis to different organs | Q34784896 | ||
| Vitamin D-3 receptor as a target for breast cancer prevention | Q35168696 | ||
| Pathways mediating the growth-inhibitory actions of vitamin D in prostate cancer | Q35168714 | ||
| Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3 | Q35462970 | ||
| Aromatase in bone: roles of Vitamin D3 and androgens | Q35586812 | ||
| Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation | Q35803526 | ||
| Vitamin D and colon carcinogenesis | Q35966627 | ||
| Aromatase inhibition: translation into a successful therapeutic approach | Q36101447 | ||
| Calcium signaling in cancer and vitamin D. | Q36218906 | ||
| Targeting cyclooxygenase-2 for prevention and therapy of colorectal cancer | Q36475129 | ||
| Inflammation in prostate carcinogenesis | Q36554784 | ||
| Stat3 promotes metastatic progression of prostate cancer. | Q36691140 | ||
| Vitamin D signalling pathways in cancer: potential for anticancer therapeutics | Q36919979 | ||
| Vitamin D and cancer incidence in the Harvard cohorts | Q37091386 | ||
| Role of vitamin D receptor in the antiproliferative effects of calcitriol in tumor-derived endothelial cells and tumor angiogenesis in vivo | Q37363014 | ||
| Identification of an alternative ligand-binding pocket in the nuclear vitamin D receptor and its functional importance in 1alpha,25(OH)2-vitamin D3 signaling | Q37511791 | ||
| The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature | Q37576901 | ||
| The role of vitamin D in cancer prevention and treatment | Q37761548 | ||
| Growth factors in the regulation of pericellular proteolysis: a review | Q38201615 | ||
| Insulin-like growth factor binding protein-3 mediates 1 alpha,25-dihydroxyvitamin d(3) growth inhibition in the LNCaP prostate cancer cell line through p21/WAF1. | Q38303196 | ||
| 1alpha, 25-dihydroxyvitamin D3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis. | Q38314103 | ||
| Cyclooxygenase-2 (COX-2) expression is an independent predictor of prostate cancer recurrence | Q38438329 | ||
| Expression of calbindin-D28k is inversely correlated with proapototic gene expression in hydrogen peroxide-induced cell death in endometrial cancer cells | Q39604006 | ||
| Vitamin D inhibits CEACAM1 to promote insulin/IGF-I receptor signaling without compromising anti-proliferative action | Q39666830 | ||
| Involvement of stress activated protein kinases (JNK and p38) in 1,25 dihydroxyvitamin D3-induced breast cell death | Q39676692 | ||
| Vitamin D deficiency promotes human breast cancer growth in a murine model of bone metastasis | Q39738745 | ||
| The transcription factors Snail1 and Snail2 repress vitamin D receptor during colon cancer progression | Q39742532 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 593-604 | |
| P577 | publication date | 2011-08-01 | |
| P1433 | published in | Best Practice and Research: Clinical Endocrinology and Metabolism | Q15755890 |
| P1476 | title | The anti-cancer and anti-inflammatory actions of 1,25(OH)₂D₃ | |
| P478 | volume | 25 |
| Q33956888 | 1, 25(OH)₂D₃ inhibits hepatocellular carcinoma development through reducing secretion of inflammatory cytokines from immunocytes |
| Q90210357 | 1,25(OH)2D3 improves blood lipid metabolism, liver function, and atherosclerosis by constraining the TGF-β/Smad signaling pathway in rats with hyperlipidemia |
| Q37700550 | 25-Hydroxyvitamin D and ankle-brachial blood pressure index in adults without peripheral artery disease. |
| Q34135803 | A review of the application of inflammatory biomarkers in epidemiologic cancer research |
| Q38640277 | Ambient ultraviolet radiation exposure and hepatocellular carcinoma incidence in the United States |
| Q37214377 | Association between serum 25(OH) vitamin D, incident liver cancer and chronic liver disease mortality in the Linxian Nutrition Intervention Trials: a nested case-control study |
| Q46625663 | C-reactive protein levels and vitamin d receptor polymorphisms as markers in predicting cachectic syndrome in cancer patients |
| Q41601067 | Chemokine CXCL1 may serve as a potential molecular target for hepatocellular carcinoma |
| Q39345445 | Differential effects of vitamin D treatment on inflammatory and non-inflammatory breast cancer cell lines |
| Q38882883 | Effect of vitamin D deficiency in developed countries |
| Q38056803 | Genetic regulation of vitamin D levels |
| Q38878644 | Inflammatory microenvironment and expression of chemokines in hepatocellular carcinoma |
| Q48253329 | Long-Chain Metabolites of Vitamin E: Metabolic Activation as a General Concept for Lipid-Soluble Vitamins? |
| Q35677400 | Low 25-Hydroxyvitamin D Levels Are Associated with Infections and Mortality in Patients with Cirrhosis |
| Q38042081 | Molecular aspects of vitamin D anticancer activity |
| Q47981174 | Oxidative stress-induced cognitive impairment in obesity can be reversed by vitamin D administration in rats |
| Q47140852 | Physiological serum 25-hydroxyvitamin D concentrations are associated with improved thyroid function-observations from a community-based program. |
| Q52649198 | Potential Use of 1-25-dihydroxyvitamin D in the Diagnosis and Treatment of Papillary Thyroid Cancer. |
| Q35046497 | Primary 1,25-dihydroxyvitamin D3 response of the interleukin 8 gene cluster in human monocyte- and macrophage-like cells |
| Q38758856 | Prodifferentiation Activity of Novel Vitamin D₂ Analogs PRI-1916 and PRI-1917 and Their Combinations with a Plant Polyphenol in Acute Myeloid Leukemia Cells |
| Q39344613 | Progesterone and calcitriol attenuate inflammatory cytokines CXCL1 and CXCL2 in ovarian and endometrial cancer cells |
| Q38152176 | Role of proinflammatory cytokines on expression of vitamin D metabolism and target genes in colon cancer cells. |
| Q44328439 | Severe 25-hydroxyvitamin D deficiency identifies a poor prognosis in patients with hepatocellular carcinoma - a prospective cohort study |
| Q33687845 | Skin, reactive oxygen species, and circadian clocks |
| Q92008641 | Ultraviolet radiation exposure and breast cancer risk in the Nurses' Health Study II |
| Q48354421 | Vitamin D administration, cognitive function, BBB permeability and neuroinflammatory factors in high-fat diet-induced obese rats. |
| Q86430251 | Vitamin D and cancer |
| Q49917764 | Vitamin D and regulation of vascular cell function |
| Q49216676 | Vitamin D deficiency and hepatitis viruses-associated liver diseases: A literature review |
| Q38412880 | Vitamin D in cancer chemoprevention |
| Q92300411 | Vitamin D intake, blood vitamin D levels, and the risk of breast cancer: a dose-response meta-analysis of observational studies |
| Q37061744 | Vitamin d: pharmacokinetics and safety when used in conjunction with the pharmaceutical drugs used in cancer patients: a systematic review |
Search more.